JEFFREY W. HENDERSON

Corporate Board Profile

Tech Score: 10/100

← Back to All Directors

Software Technology Evidence

3 mention(s) identify JEFFREY W. HENDERSON as having software/technology expertise.

Company Filing Date Evidence Reason
HALOZYME THERAPEUTICS, INC. 2016-03-23 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration. Holds a Bachelor of Science degree in electrical engineering, indicating a technical background relevant to software and programming.
HALOZYME THERAPEUTICS, INC. 2019-03-22 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration. Holds a Bachelor of Science degree in electrical engineering, which is a technical field related to software and programming.
HALOZYME THERAPEUTICS, INC. 2021-03-26 He holds a B.S. degree in electrical engineering from Kettering University and a M.B.A. from Harvard Graduate School of Business Administration. As Cardinal Health’s Chief Financial Officer, Mr. Henderson led various departments within the company, including finance, information technology and global shared services. Mr. Henderson holds a B.S. degree in electrical engineering and has operational responsibility for information technology, indicating technical skills relevant to software.

BECTON DICKINSON & CO

Filing Date Source Excerpt
2018-12-03 Jeffrey W. Henderson, 54, has been a director since August 2018... Audit Committee members include Bertram L. Scott—Chair, R. Andrew Eckert, Jeffrey W. Henderson, David F. Melcher, Willard J. Overlock, Jr., Rebecca W. Rimel... Compensation and Management Development Committee members include Marshall O. Larsen—Chair, Jeffrey W. Henderson, Christopher Jones, Gary A. Mecklenburg, David F. Melcher, Bertram L. Scott... Fiscal Year 2018 Non-Management Directors’ Compensation table shows Jeffrey W. Henderson total compensation as $119,476.
2020-12-17 Jeffrey W. Henderson, 56, has been a director since August 2018. ... Mr. Henderson is an experienced healthcare executive... Committee memberships: Audit Committee, Compensation and Management Development Committee. Fiscal Year 2020 Non-Management Directors’ Compensation: $322,072.
2021-12-16 Jeffrey W. Henderson | 57Retired Chief Financial Officer of Cardinal Health Inc. Director Since:2018 Independent:Yes Committees: Audit, Compensation and Human Capital. Non-management director compensation table shows total compensation of $326,172.
2022-12-15 Jeffrey W. Henderson | 58Retired Chief Financial Officer of Cardinal Health Inc...Independent:Yes...Committees: Audit (Chair), Compensation and Human Capital...Fiscal 2022 director compensation: Jeffrey W. Henderson 318,580
2023-12-14 Jeffrey W. Henderson | 59 Former Chief Financial Officer of Cardinal Health Inc. Director Since: 2018 Independent: Yes Committees: Audit (Chair), Compensation and Human Capital Fiscal 2023 director compensation: Total 357,778
2024-12-19 Mr. Henderson is an experienced healthcare executive who brings to the Board a deep knowledge of the industry, along with strong financial, strategic and operational expertise.

FIBROGEN INC

Filing Date Source Excerpt
2016-04-22 Jeffrey W. Henderson, age 51, has served on our board of directors since August 2015. ... Our audit committee consists of Messrs. Riggs, Edwards, Henderson, Schoeneck, and Stern and Dr. Kurkijärvi. ... The following table sets forth information regarding non-cash compensation earned by or paid to our non-employee directors during 2015: Jeffrey W. Henderson $305,073.
2017-04-24 Jeffrey W. Henderson, age 52, has served on our board of directors since August 2015. He serves on the Audit committee. Director compensation in 2016 was $187,965.
2018-04-24 Jeffrey W. Henderson, age 53, has served on our board of directors since August 2015. Mr. Henderson has 30 years of financial, commercial and pharmaceutical industry experience. He most recently served as chief financial officer for Cardinal Health, Inc. from 2005 until 2014. ... Our board of directors has determined that Messrs. Henderson ... who comprise our nominating and corporate governance committee, satisfy the independence standards for those committees ...
2020-04-23 Jeffrey W. Henderson, age 55, has served on our board of directors since August 2015. ... Mr. Henderson was a member of the nominating and corporate governance committee prior to the start of 2019 until September 5, 2019 when he became the Chair of this committee.
2021-04-13 Jeffrey W. Henderson, age 56, has served on our board of directors since August 2015. ... Our audit committee consists of Mr. Edwards, Dr. Ho and Mr. Lema. ... Our nominating and corporate governance committee consists of Ms. Blaug, Dr. Cravatt, and Messrs. Henderson and Riggs. Mr. Henderson was the Chair of our nominating and corporate governance committee throughout 2020. ... The following table sets forth information regarding compensation earned by or paid to our non-employee directors during fiscal year 2020: ... Jeffrey W. Henderson Fees Earned or Paid in Cash: $60,000, Stock Option Awards: $148,442, RSU Awards: $153,643, Total: $362,085.
2022-04-29 Jeffrey W. Henderson, age 57, has served on the Board since 2015... He serves on Audit and Compensation committees... Total compensation in 2021 was $247,072.
2023-04-27 Jeffrey W. Henderson, age 58, has served on the Board since August 2015. ... Our Audit Committee consists of Mr. Edwards, Dr. Ho and Mr. Lema. ... Our Nominating and Corporate Governance Committee consists of Messrs. Schoeneck and Henderson, Ms. Blaug, and Dr. Cravatt. ... The following table sets forth information regarding compensation earned by or paid to our non-employee directors during fiscal year 2022: ... Jeffrey W. Henderson $340,704 ...
2024-04-24 Jeffrey W. Henderson, age 59, has served on our board of directors since August 2015. Mr. Henderson serves on the Audit Committee. Director compensation table shows total $370,534.

HALOZYME THERAPEUTICS, INC.

Filing Date Source Excerpt
2016-03-23 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration.
2017-03-24 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration.
2018-03-22 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration.
2019-03-22 He holds a Bachelor of Science degree in electrical engineering from Kettering University and a Master of Business Administration from Harvard Graduate School of Business Administration.
2020-03-20 He holds a B.S. degree in electrical engineering from Kettering University and a M.B.A. from Harvard Graduate School of Business Administration.
2021-03-26 He holds a B.S. degree in electrical engineering from Kettering University and a M.B.A. from Harvard Graduate School of Business Administration. As Cardinal Health’s Chief Financial Officer, Mr. Henderson led various departments within the company, including finance, information technology and global shared services.
2022-03-25 He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.
2023-03-24 He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration. He has nearly 30 years of financial, commercial and pharmaceutical industry expertise.
2024-03-15 He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.
2025-03-18 He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.

QUALCOMM INC/DE

Filing Date Source Excerpt
2019-01-24 Jeffrey W. Henderson Chairman of the Board Chair: Audit Committee Advisory Director to Berkshire Partners LLC Fiscal 2018 Director Compensation: Fees Earned or Paid in Cash $249,625, Stock Awards $200,038, All Other Compensation $17,112, Total $466,775
2020-01-23 Mr. Henderson is Chair of the Audit Committee. All of the members of the Audit Committee are independent directors within the meaning of Rule 5605 of the NASDAQ Stock Market LLC (NASDAQ Rule 5605) and Rule 10A-3(b)(1)(ii) of the Securities Exchange Act of 1934, as amended, and Messrs. Henderson, Smit and Vinciquerra are audit committee financial experts as defined by the SEC.
2021-01-21 JEFFREY W. HENDERSON INDEPENDENT DIRECTOR AGE:56 DIRECTOR SINCE:2016 COMMITTEES:Audit (Chair)
2022-01-20 JEFFREY W. HENDERSON INDEPENDENT DIRECTOR AGE: 57DIRECTOR SINCE: 2016COMMITTEES: Audit (Chair)OTHER PUBLIC COMPANY BOARDS:Becton, Dickinson and Company (since August 2018)Halozyme Therapeutics, Inc. (since August 2015)FibroGen, Inc. (since August 2015)
2023-01-19 JEFFREY W. HENDERSON INDEPENDENT DIRECTOR AGE: 58DIRECTOR SINCE: 2016COMMITTEES: Audit (Chair)
2024-01-18 JEFFREY W. HENDERSON INDEPENDENT DIRECTOR AGE: 59 DIRECTOR SINCE: 2016 COMMITTEES: Audit (Chair) OTHER PUBLIC COMPANY BOARDS: Becton, Dickinson and Company (since August 2018) Halozyme Therapeutics, Inc. (since August 2015) FibroGen, Inc. (since August 2015)
2025-01-23 JEFFREY W. HENDERSON INDEPENDENT DIRECTOR AGE: 60 DIRECTOR SINCE: 2016 COMMITTEES: Audit (Chair) OTHER PUBLIC COMPANY BOARDS: Becton, Dickinson and Company (since August 2018) Halozyme Therapeutics, Inc. (since August 2015)

Data sourced from SEC filings. Last updated: 2026-02-03